Literature DB >> 17973304

Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.

Marc Ferrante1, Sarah Declerck, Gert De Hertogh, Gert Van Assche, Karel Geboes, Paul Rutgeerts, Freddy Penninckx, Séverine Vermeire, Andre D'Hoore.   

Abstract

BACKGROUND: During the course of their disease, about 30% of patients with ulcerative colitis (UC) will undergo proctocolectomy with ileal pouch-anal anastomosis (IPAA). We evaluated the outcome of IPAA in a Belgian referral center.
METHODS: Clinical charts were reviewed for pre- and postoperative disease course, functional outcome, and complications in all patients with UC (n = 182) and indeterminate colitis (n = 2) who underwent IPAA in 1990-2004.
RESULTS: Follow-up data were available in 173 out of 184 patients (67 female, median age at proctocolectomy 39.0 years). Median functional Oresland score 1 year after IPAA was 3 (range 0-11). Early postoperative complications were seen in 27% of patients. After a median (interquartile range) follow-up of 6.5 (3.4-9.9) years, 35% of patients developed septic and/or obstructive complications. Forty-six percent of patients developed at least 1 episode of pouchitis. Risk factors for pouchitis were the presence of extraintestinal manifestations (odds ratio [OR] 1.92 (1.23-3.01), P = 0.004) and younger age at proctocolectomy (P = 0.004). Chronic pouchitis was present in 33 patients and associated with extraintestinal manifestations (OR 2.93 (1.13-7.62), P = 0.027), backwash ileitis (OR 9.28 (1.71-50.49), P = 0.010), and length of follow-up (P = 0.004). Pouch failure occurred in 5% of patients.
CONCLUSIONS: Although proctocolectomy with IPAA surgery has a good functional outcome, postoperative complications, especially pouchitis, remain considerable in patients with UC.

Entities:  

Mesh:

Year:  2008        PMID: 17973304     DOI: 10.1002/ibd.20278

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  38 in total

Review 1.  The clinical impact of primary sclerosing cholangitis in patients with an ileal pouch-anal anastomosis for ulcerative colitis.

Authors:  Monira Rahman; Paul Desmond; Neil Mortensen; Roger W Chapman
Journal:  Int J Colorectal Dis       Date:  2011-01-29       Impact factor: 2.571

Review 2.  Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.

Authors:  Bo Shen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

3.  Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis.

Authors:  Orlaith B Kelly; Morgan Rosenberg; Andrea D Tyler; Joanne M Stempak; A Hillary Steinhart; Zane Cohen; Gordon R Greenberg; Mark S Silverberg
Journal:  J Crohns Colitis       Date:  2015-12-30       Impact factor: 9.071

4.  ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.

Authors:  Jennifer A Coukos; Lauren A Howard; Janice M Weinberg; James M Becker; Arthur F Stucchi; Francis A Farraye
Journal:  Dig Dis Sci       Date:  2012-02-07       Impact factor: 3.199

Review 5.  Surgical treatment of ulcerative colitis in the biologic therapy era.

Authors:  Alberto Biondi; Marco Zoccali; Stefano Costa; Albert Troci; Ettore Contessini-Avesani; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

6.  Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes.

Authors:  Jeffrey D McCurdy; Edward V Loftus; William J Tremaine; Thomas C Smyrk; David H Bruining; Darrell S Pardi; Laura E Raffals; John B Kisiel; Nayantara Coelho-Prabhu; Sunanda V Kane; William A Faubion; Konstantinos A Papadakis
Journal:  Inflamm Bowel Dis       Date:  2013-10       Impact factor: 5.325

7.  Treatment strategy for preventing pouchitis as a postoperative complication of ulcerative colitis: the significance of the management of cuffitis.

Authors:  Takuzo Hashimoto; Michio Itabashi; Shinpei Ogawa; Tomoichiro Hirosawa; Yoshiko Bamba; Sanae Kaji; Mamiko Ubukata; Sayumi Nakao; Shingo Kameoka
Journal:  Surg Today       Date:  2014-07-15       Impact factor: 2.549

8.  Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience.

Authors:  Bram Verstockt; Charlotte Claeys; Gert De Hertogh; Gert Van Assche; Albert Wolthuis; André D'Hoore; Séverine Vermeire; Marc Ferrante
Journal:  United European Gastroenterol J       Date:  2019-08-20       Impact factor: 4.623

9.  Preoperative Clostridium difficile infection is not associated with an increased risk for the infection in ileal pouch patients.

Authors:  Chao Sun; Peng Du; Xian-rui Wu; Elaine Queener; Bo Shen
Journal:  Dig Dis Sci       Date:  2014-02-07       Impact factor: 3.199

10.  Colorectal neoplasia in IBD--a single-center analysis of patients undergoing proctocolectomy.

Authors:  Rüdiger Meyer; Tilman Laubert; Martin Sommer; Claudia Benecke; Hendrik Lehnert; Klaus Fellermann; Hans-Peter Bruch; Tobias Keck; Christoph Thorns; Jens K Habermann; Jürgen Büning
Journal:  Int J Colorectal Dis       Date:  2015-04-26       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.